OXT and Alzheimer disease: There is extensive evidence, especially from non-human animal studies,56 that dopaminergic deficits result in less-motivated behavior, which resembles the behavior of patients with apathy.57 Thus, psychostimulants such as methylphenidate and dextroamphetamine are usually prescribed to treat apathy in bvFTD.47 A Cochrane paper suggested that methylphenidate was the only drug with positive response in apathy, although this evidence was primarily obtained in AD patients’ samples.48 Finger et al. investigated the use of intranasal oxytocin and suggested that it may improve the levels of apathy.58